Cargando…
Metronomic chemotherapy: changing the paradigm that more is better
The introduction of the “maximum tolerated dose” in usual treatment protocols (and its concomitant overt toxicity) made necessary the imposition of rest periods between cycles of therapy—a practice that not only involves re-growth of tumour cells, but also growth of selected clones resistant to the...
Autores principales: | Scharovsky, O.G., Mainetti, L.E., Rozados, V.R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669231/ https://www.ncbi.nlm.nih.gov/pubmed/19370174 |
Ejemplares similares
-
Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017) -
Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
por: Mainetti, Leandro E., et al.
Publicado: (2020) -
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
por: Rosé, Adriana, et al.
Publicado: (2016) -
Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014) -
Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)